Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients
- 1 February 2023
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (5) , 558-561
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022Emerging Infectious Diseases, 2022
- Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variantThe Journal of Heart and Lung Transplantation, 2022
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort studyThe Lancet, 2022
- The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get?Cells, 2022
- Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022Eurosurveillance, 2022
- Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic ReviewClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2022
- The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicCell, 2021
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Nature, 2021
- Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysisEuropean Journal of Preventive Cardiology, 2021